Europe August 8, 2023July 16, 2024 Patent Box Regimes in Europe, 2023 The aim of patent boxes is generally to encourage and attract local research and development (R&D) and to incentivize businesses to locate IP in the country. However, patent boxes can introduce another level of complexity to a tax system, and some recent research
0 Comments
In this article 4523.T-JP Follow your favorite stocksCREATE FREE ACCOUNT The newly FDA approved Alzheimer’s treatment Leqembi is prepared at Abington Neurological Associates in Abington, PA., on Tuesday, November 7, 2023.  Hannah Yoon | The Washington Post | Getty Images The breakthrough Alzheimer’s drug Leqembi slowed disease progression in patients over three years, demonstrating the
0 Comments
Microsoft delivered an overall strong quarter after Tuesday’s market close, but a miss on Azure revenue growth put shares under pressure in extended-hours trading. Revenue increased about 15% year over year to $64.73 billion in its fiscal 2024 fourth quarter, beating the Street consensus estimate of $64.39 billion, according to data from LSEG. Earnings per
0 Comments
Sdi Productions | E+ | Getty Images Home affordability has slightly improved for buyers this summer, according to a recent report.  The median new mortgage payment was $2,167 in June, a 2.4% decline from $2,219 in May, according to new data from the Mortgage Bankers Association. The index measures how new monthly mortgage payments change
0 Comments
Capital Allowances in Europe, 2024 | Tax Foundation Skip to content Although sometimes overlooked in discussions about corporate taxation, capital allowances play an important role in a country’s corporate tax baseThe tax base is the total amount of income, property, assets, consumption, transactions, or other economic activity subject to taxation by a tax authority. A
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters An older, once-daily drug for diabetes and obesity from Novo Nordisk called liraglutide may slow the progression
0 Comments